The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell analysis showing that the growth of nuclear medicine in the future will come through therapeutic radiopharmaceuticals (radiotherapeutics). Revenue for Xofigo – a product used in the treatment of prostate and bone cancers – reached EUR 157 million (US$ 209 million) in 2014.

Researchers at the University of California, San Diego School of Medicine have identified a key piece in the complex molecular puzzle underlying heart failure.

Carroll Hospital Center physicians will now have 24/7 remote access to the University of Maryland Medical Center’s (UMMC) Brain Attack Team through a new telemedicine service for stroke patients.

George Adams, M.D., an interventional cardiologist with North Carolina Heart and Vascular, successfully treated a patient having an acute myocardial infarction (AMI) with the Aspire Mechanical Thrombectomy System.

In an analysis of outcomes of about 12,000 patients who underwent transcatheter aortic valve replacement (TAVR), death rate after one year was nearly one in four, according to a study in the March 10 issue of JAMA. Of those alive at 12 months, almost half had not been rehospitalized and approximately 25 percent had only one hospitalization.

Carestream is demonstrating its new Touch Ultrasound System at the American Institute of Ultrasound in Medicine (AIUM) annual meeting, March 21-25.

TeraRecon unveiled the latest release of the company’s flagship iNtuition enterprise viewing solutions in combination with the second-generation of its iNteract+ interoperability platform at the annual European Congress of Radiology (ECR) meeting, March 4-8 in Vienna.

VTEC, NYU Langone, venous therapies, deep vein thrombosis, DVT, PE

NYU Langone Medical Center has announced the creation of a new multidisciplinary Venous Thromboembolic Disease Center (VTEC) to treat those with life-threatening blood clots. The new VTEC delivers advanced detection, comprehensive care and effective management for patients experiencing a venous thromboembolic event.
atrial fibrillation, women, seniors, guidelines, blood thinners, DCRI

Nearly all women and people over 65 in the United States with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research Institute (DCRI).
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now